Its low molecular weight (~340 Da) means it reaches tissue compartments that larger peptides may not, and its stability profile is well-suited to combination formulations
It is not approved by the MHRA and cannot legally be prescribed or dispensed in the UK as of May 2026
Patients expressing interest in this product must complete our waiver, the approval or denial of eligibility is determined based on the patients answers and supplied medical history information by our clinicians.
5, t max,semaglutide,day10 did not change with water volume, but increased with longer post-dose fasting
The topline findings from SURPASS-CVOT, disclosed before publication of the main manuscript [11], reported a hazard ratio of 0.92 (95.3% CI 0.831.01) for 3P-MACE in favor of tirzepatide, confirming noninferiority to dulaglutide